1 / 21

Miracle Cure? #1: Lipid Rescue® for Local Anesthetic Toxicity

Miracle Cure? #1: Lipid Rescue® for Local Anesthetic Toxicity. Joe Dietrick, CRNA, M.A . Truman Medical Center Kansas City, MO. Objectives. Review history of cardiovascular collapse with local anesthetics Discuss effect of local anesthetic toxicity on myocardial function

brian
Download Presentation

Miracle Cure? #1: Lipid Rescue® for Local Anesthetic Toxicity

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Miracle Cure? #1:Lipid Rescue® for Local Anesthetic Toxicity Joe Dietrick, CRNA, M.A. Truman Medical Center Kansas City, MO

  2. Objectives • Review history of cardiovascular collapse with local anesthetics • Discuss effect of local anesthetic toxicity on myocardial function • Discuss treatment options, focusing on infusion of Intralipids®

  3. History of the world… • Anesthesia for CS • Epidurals in 70 – 80’s 1 • Short-acting  Bupivacaine 0.5 – 0.75% • 1979: CV collapse with etidocaine/bupivacaine • Difficult (impossible) prolonged resuscitation • 1983: 59 cardiac (35 OB) cases • 39 Epidurals, 27 used Bupiv 0.75% • 31 deaths (24 mother &/or baby) • 83% of LA toxicity  neurologic injury / death • FDA: Bupiv 0.75% not recommended for OB

  4. History of the world… Part II • Early ’90s • Pencil point spinal needles   SAB for CS •  epidural injection of high concentration LA • Late ’90s • Ropivacaine approved for general use • Generally 30% improvement in safety margin • Max concentration for OB: 0.5% (150 mg)

  5. CV Toxicity2 • Act on Na+ channel inside cell • Reversible nerve conduction block • CNS: most susceptible to toxic effects • CV effects •  cardiac conduction   PR, QRS • Inhibition of K+ channel  QTc • Dextrorotary   K+ blk • Highly selective for vascular K-ATP channels • Bupiv dissociation 10x longer vs. Lido

  6. Stay out of trouble2 • Potency • Ropiv < Bupiv • CV toxicity: Ropiv < Bupiv • Animal studies appear to suggest dose to induce CV toxicity: Ropiv dose approx twice Bupiv dose

  7. What Weinberg says. • Incidentally found lipid emulsion reversed LA-induced cardiac arrest • 2003 report with dogs, Bupiv10 mg/kg3 • 10’ CPR • Lipid 20% 4 ml/kg vs NS • Survival • TX: 6/6 • Ctrl: 0/6

  8. Perceived MOA • 2 theories5 • Fat sink  reverse [gradient] for lipophilics • LA inhibits FA entry to mitochondria • Bupiv effect on myocardial acidosis4 • Bupiv or NS injected, then VF induced • Monitored 20’ or pHm = 7.0 • Bupiv Intralipid; both groups defibrillated • Bupiv group had less myocardial acidosis • “inhibition of cellular metabolism”

  9. Really? • www.lipidrescue.org • Lists studies & case reports • Published (17) • Submitted case reports (a bunch) • Recommends standard resuscitation, then • Intralipid® 20% • 1.5 ml/kg bolus, MR for persistent asystole • 0.25 ml/kg/min for 30-60’

  10. ACLS is da’ bomb – or it bombs • Ropivacaine & Levobupivacaine have had successful standard resuscitations • Anesthesiology: Mar 2007 • Mult letters regarding Rosenblatt case report • ROSC immed after lipid, but 20’ of conventional management could have contributed • c/o shocking asystole • c/o global term “LA toxicity” vs racemic Bupiv, and ? CNS efficacy • “Failure to ventilate & maintain cardiac perfusion?”

  11. Compared to standard resuscitation6 • Weinberg: Lipid vs. Epinephrine vs. saline6 • Rats, Bupiv 20 mg/kg  asystole • Lipid: 5 ml/kg + 0.5 ml/kg/min • Epi: 30 μg/kg • Doses repeated @ 2.5’ & 5’ • ROSC @ 10’ • Lipid 5/5 • Epi 4/5 • Ctrl 2/5

  12. Lipid EPI NS Compared to standard resuscitation6 • Weinberg: Lipid vs. Epinephrine vs. saline6 • Rats, Bupiv 20 mg/kg  asystole • Lipid: 5 ml/kg + 0.5 ml/kg/min • Epi: 30 μg/kg • Doses repeated @ 2.5’ & 5’ • ROSC @ 10’ • Lipid 5/5 • Epi 4/5 • Ctrl 2/5

  13. Lipids don’t help ACLS9 • Hicks (2009) swine model • Bupivacaine 10 mg/kg • CPR x 5’ • EPI 100 μg/kg + vasopressin 1.5 units/kg • EPI 15 every 3’ • If no ROSC @ 20’ • Intralipids 20% 4 ml/kg • Intralipids did not improve rates of ROSC

  14. ‘Cause you give too much EPI8 • Hiller’s (2009) rat model • Received bupivacaine 20 mg/kg, • CPR x 3’ • Saline control • Intralipid control: 30%, 5ml/kg (@ 2 & 5’) • Compared escalating doses of EPI • All with Intralipid treatment • μg/kg: 0, 1, 2.5, 10, 25 • ROSC among all animals in a group • Lipid + Epi (1 or 2.5 μg/kg)

  15. Hiller (2009)8

  16. You pigs… • Bushey et al (2011)12 • Swine with bupivacaine & hypoxic arrest • ACLS, 12 per group (lipids vs saline) • Intralipids 4 ml/kg + infusion @ 4.25’ mark • Outcome • ROSC: control = 4, lipid = 6 • pH @ 4.25’: 7.33 (both groups) • Success in animals other than pigs • Pigs closer to humans

  17. Risk?5 • Pulmonary vasoconstriction? • Editorial opinion by Picard & Meek: • Animal studies: benefit >> risk • Brull (2008): poss allergic rxn,  ICP • Imprudent to withhold in toxic events • Marwick (2009) reported recurrence • Bupiv brach plexus blk  asystole • 40’ after termination of lipid  VT • Recommend 1000 ml available

  18. Risk – push the limit10 • Intralipids 20% • 20, 40, 60, or 80 ml/kg • Rats euthanized & histologically examined • Estimated LD50 = 67 (±10.7) ml/kg • Lung & liver microscropic ∆ • NL: Myocardium, brain, pancreas, & kidney • Safe at doses used

  19. And all this means • If you use cardiotoxic doses (volume blocks) of any local anesthetic • Have a plan • Have Intralipid® emulsion available • Have administration instructions • Package these together • Consider in other lipid-soluble drug toxicities www.lipidrescue.org

  20. Courtesy: K. McCully, CRNA

  21. References • Herlocker, T. & Wedel, D. (2002). Local Anesthetic Toxicity—Does Product Labeling Reflect Actual Risk? Regional Anesthesia and Pain Medicine, 27 (6):562–567. • Leone, S. et al (2008). Pharmacology, toxicology, and clinical use of new long acting local anesthetics, ropivacaine and levobupivacaine. ACTA BIOMED 79: 92-105. • Weinberg G, et al (2003). Lipid emulsion infusion rescues dogs from bupivacaine-induced cardiac toxicity. Reg Anesth Pain Med;28:198–202. • Weinberg G, et al (2004). The effect of bupivacaine on myocardial tissue hypoxia and acidosis during ventricular fibrillation. Anesth Analg. 98(3):790-5. • Picard, J. & Meek, T. (2006). Lipid emulsion to treat overdose of local anaesthetic: the gift of the glob. Anaesthesia, 61:107–109. • Weinberg GL et al (2008). Resuscitation with lipid versus epinephrine in a rat model of bupivacaine overdose. Anesthesiology, 108(5):907-13. • Bania T, et al (2007). Hemodynamic effects of intravenous fat emulsion in an animal model of verapamil toxicity resuscitated with atropine, calcium and saline. Acad. Emerg. Med, 14:105-11. • Hiller, D et al (2009). Epinephrine Impairs Lipid Resuscitation from Bupivacaine Overdose. Anesthesiology, 111(3):498-505. • Hicks, S et al(2009). Lipid Emulsion Combined with Epinephrine and Vasopressin Does Not Improve Survival in a Swine Model of Bupivacaine-induced Cardiac Arrest. Anesthesiology, 111(1):138-146. • Hiller, D et al. (2010). Safety of high volume lipid emulsion infusion: a first approximation of LD%) in rats. Regional Anesthesia & Pain Medicine, 35(2):140-144. • Neal, J et al (2010). Local Anesthetic Systemic Toxicity 2010. Regional Anesthesia & Pain Medicine, 35(2):152-193. • Bushey, B et al (2011). Combined Lipid Emulsion and ACLS Resuscitation Following Bupivacaine- and Hypoxia-Induced Cardiovascular Collapse in Unanesthetized Swine. AANA Journal, 79(2): 129-138.

More Related